Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Darrin Uecker is recorded as CTO at Pulse Biosciences, Inc. (PLSE). Pulse Biosciences, Inc. reported in an 8-K filed September 23, 2022 that Darrin Uecker was appointed Chief Technology Officer, effective September 20, 2022. Darrin Uecker has spoken on 5 earnings calls across 1 company, most recently for Pulse Biosciences, Inc. on March 28, 2024.
“Effective September 20, 2022, the board of directors (the "Board") of the Company appointed Kevin Danahy to serve as Chief Executive Officer of the Company and Darrin Uecker to serve as Chief Technology Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2022-09-20–present
Recorded roles and call appearances connecting this person to public companies.
CTO
2022-09-20–present
Other people whose current roles at this company are on record from its filings.
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
